This “tumor elicited inflammation” is characterized by the infiltration of myeloid and Th17 cells to colorectal tumors, and the production of cytokines such as IL-23 and IL-17 that support tumor cell proliferation and survival [6, 7]. The gene discussed is IL17A; the disease is neoplasm.